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Introduction: Schwann cells support neurons 
within the Peripheral Nervous System (PNS) 
and are responsible for the protection and 
myelination of the axon. When nervous tissue 
is damaged within the PNS, Schwann cells 
will dedifferentiate, proliferate, and migrate 
towards the site of injury before re-
differentiating to form Bunger bands1. Due to 
this capability, Schwann cell transplants have 
been used in attempt to treat damaged 
nervous tissue. In the Central Nervous 
System (CNS), due to inadequate growth and 
cell signaling factors, there is little success 
with these transplants2. Schwann cell 
proliferate under in vitro conditions when 
stimulated by the neuronal growth factor 
heregulin and forskolin a pharmacological 
activator of cyclic adenosine monophosphate 
(cAMP)3. In recent years, researchers have 
been using phosphodiesterase inhibitors as an 
alternative form of treatment for spinal cord 
damage, Multiple Sclerosis, Alzheimer’s 
Disease, and other neurodegenerative 
diseases4. Phosphodiesterase inhibitors 
increases the abundance of the universal 
secondary messenger, cAMP by hydrolyzing 
a family of enzymes called 
phosphodiesterases5. Intracellular cAMP 
binds to the regulatory subunit of Protein 
Kinase A (PKA) which allows the catalytic 
subunits to phosphorylate protein substrates. 
PKA is anchored by A kinase-anchoring 
proteins (AKAPs) that are known to scaffold 
phosphodiesterases, phosphatases, and other 
signaling molecules. A critical AKAP that can 
be found within Schwann cells is ezrin; a 
protein responsible for the formation of the 
cytoskeleton, actin filaments, and microvilli 
as well as serving as a transport linker 
between the cytoplasm and cell membrane6. 
Currently there is no literature that explores 
the effects of phosphodiesterase inhibitors 
such as rolipram on Schwann cells 
proliferation and ezrin expression. 
Our objectives for this research project was: 
1. To determine the optimal concentration(s) 
of rolipram that is required for cell 
proliferation.  
2. To examine the expression of ezrin before 
and after treating with rolipram. 
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Conclusions: 
• Cells treated with both heregulin and 
forskolin appear to be higher in cell 
density in comparison to N2, 
heregulin, and foskolin. 
• Schwann cell proliferation appears to 
be optimal at a dose of 0.5 µM and 
10 µM rolipram at both 12 and 24 
hours time points. 
• Expression of ezrin was the highest 
in cells treated with heregulin and 
forskolin.
Morphology of Schwann Cells When Incubated Under Different Mitogenic Conditions: 
Rolipram Dose Response: 
Figure 2: Immortalized Schwann cells were cultured in N2 (control) media, heregulin (H) 12.5 ng/mL, forskolin (F) 1 µM, heregulin + forskolin (H+F) and media containing growth media (GM) at A) 6 hours, B) 12 hours, and C) 24 hours while treated under 
various concentrations of rolipram (µM). Cell proliferation was measured using MTT Proliferation Assay (n=1).  
Figure 1: Immortalized Schwann cells were cultured in A) N2 (control) media, B) heregulin (H) 12.5 ng/mL, C) forskolin (F) 1 µM, D) heregulin + forskolin (H+F).
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Ezrin Immunoblot: 
                                                            
Figure 4: Quantitative expression of ezrin as percent control over actin. Cells 
treated with heregulin + forskolin had the highest overall ezrin expression 
(n=3).
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Figure 3: Schwann cells were incubated under N2 (control) media, heregulin (H) 12.5 ng/mL, 
forskolin (F) 1 µM, or heregulin + forskolin (H+F). The figure above is representation of one 
immunoblot from three independent experiments.  
